MAPT and diabetes mellitus: Cognitive dysfunction associated with neuropathological hallmarks, such as amyloid deposition, tau protein hyperphosphorylation, and gliosis, was used to highlight several primary concerns during AD and diabetes mellitus (DM) (Halmos and Suba 2016).